About Us | Our Companies
Specialist Expertise Across Healthcare Technologies
We are a group of specialist healthcare companies with capabilities spanning radioisotope production, cancer treatment technologies, medical device development, manufacturing, vascular access products, and interventional healthcare solutions.
Through Theragenics, Arrotek, and Galt Medical, we bring together decades of experience across multiple healthcare sectors. While each company focuses on its own specialist area, together we provide a broad range of capabilities that support customers throughout the healthcare industry.
Three Companies. One Shared Purpose.
Complimentary expertise across the medical technology spectrum to improve patient outcomes worldwide.
RADIOISOTPES. ONCOLOGY. INNOVATION
Leaders in radioisotope production and brachytherapy solutions for cancer treatment and nuclear medicine applications.
ACCESS. DELIVERY. PERFORMANCE
Tusted vascular access and inverventional products that support clinicians and improve patient care.
DESIGN. DEVELOP. DELIVER
Innovative deign and development of minimally invasive medical devices from concept to commercialization.
MANUFACTURING EXCELLENCE
COSTA RICA
State-of-the-art manufacturing facility in Costa Rica delivering scaleable production, precision, and quality for the global medical device industry.
Three Companies. One Shared Purpose.
Complimentary expertise across the medical technology spectrum to improve patient outcomes worldwide.

RADIOISOTPES. ONCOLOGY. INNOVATION
Leaders in radioisotope production and brachytherapy solutions for cancer treatment and nuclear medicine applications.

ACCESS. DELIVERY. PERFORMANCE
Tusted vascular access and inverventional products that support clinicians and improve patient care.

DESIGN. DEVELOP. DELIVER
Innovative deign and development of minimally invasive medical devices from concept to commercialization.

GLOBAL REACH
Servicing customers worldwide
QUALITY & COMPLIANCE
Committed to the highest standards
COLLABORATIVE PARTNERSHIPS
Working together to deliver innovative solutions.
IMPROVING LIVES
Focused on better outcomes for patients.
Radioisotopes, Radiopharmaceuticals & Oncology Technologies
Founded in 1981, Theragenics has more than four decades of experience supporting cancer treatment and nuclear medicine. We are a leader in brachytherapy and radioisotope production, supplying products and technologies used by healthcare providers, researchers, and radiopharmaceutical organizations worldwide. Through our expertise in isotope manufacturing, quality systems, and regulatory compliance, we continue to play an important role in advancing oncology and nuclear medicine.

Vascular Access & Interventional Products
For more than 35 years, Galt Medical has developed and manufactured products used in vascular access, interventional radiology, interventional cardiology, and other minimally invasive procedures. Our portfolio includes a wide range of access and procedural devices trusted by clinicians worldwide. Through a focus on quality, reliability, and clinical performance, we have built a strong reputation as a trusted partner to healthcare providers and medical device companies.

Learn more about Galt Medical →
Â
Medical Device Design, Development & Manufacturing
Founded in 2005, Arrotek specializes in the design, development, and manufacture of minimally invasive medical devices. Our facility in Ireland is a centre of excellence for catheter technologies and advanced device development, supporting customers from concept through to commercialization. In the United States, our Massachusetts operation—formerly NeedleTech Products provides advanced device development, expertise in specialty needles, precision metal components, rapid prototyping, and engineering services. Together, these capabilities help bring innovative medical technologies to market.
Learn more ArroTek →

Supporting both Arrotek and Galt Medical is our advanced manufacturing facility in Costa Rica.
Located in the Coyol Free Zone, the facility provides scalable manufacturing for specialized medical needles, guidewires, precision components, and complete medical devices. With cleanroom manufacturing, pilot production, and commercial-scale capabilities, it provides a seamless pathway from product development to full-scale production.

From Concept to Patient Care
Healthcare innovation doesn’t end with a great idea. It requires design expertise, manufacturing excellence, proven clinical technologies, and the ability to deliver solutions that make a meaningful difference to patients.
Through Theragenics, Galt Medical and Arrotek, we support that journey every step of the way, from radioisotope production, and cancer treatment solutions to concept development/minimally invasive device design to precision manufacturing of vascular access technologies. Together, we help transform ideas into technologies that improve and save lives.
End-to-End Solutions. Advancing Healthcare.
From initial concepts to life-changing patient outcomes.
More Than 100 Years of Combined Experience
Over four decades, Theragenics, Galt Medical, and Arrotek have built a strong foundation across oncology, radioisotopes, medical device development, manufacturing, and interventional healthcare technologies. While each company has its own history and specialist focus, together we represent decades of innovation, engineering excellence, and a shared commitment to advancing healthcare worldwide.
Theragenics Timeline
2021
Theragenics celebrates its 40th anniversary.
2019
Theragenics acquires Arrotekâ„¢ Medical, a full-service medical device design consultancy, expanding operations into Sligo, Ireland.
2013+
Thergenics becomes a private company via acquisition by Juniper Investment Company. Theragenics continues to build on its foundation as a leading medical device company.Â
2011
Theragenics receives FDA 510(k) clearance for AgX100®, an Iodine-125 based brachytherapy seed.
2008
Theragenics acquires NeedleTech Products, adding manufacturing capabilities in specialty needles.
2006
Theragenics expands into interventional radiology and cardiology with the acquisition of Galt Medical, a manufacturer of vascular access devices.
2005
Theragenics acquires CP Medical, a manufacturer of sutures and wound closure devices for veterinary and medical applications.
2003
Theragenics diversifies its product line by purchasing an existing U.S. Iodine-125 prostate business. The purchase enabled Theragenics to supply both Palladium-103 and Iodine-125 based seeds.
1998
TheraSeed® receives CE Marking, which allows Theragenics to market the device throughout Europe.
1987
The first patient was treated with TheraSeed®.
1986
TheraSeed®, a Palladium-103-based brachytherapy treatment, receives 510(k) clearance from the FDA.
1981
Theragenics was originally founded as Nuclear Medicine, Inc. by a group of physicists at the Georgia Institute of Techology, with an initial focus to develop radiological devices to treat cancer.
271,000 +
Patients treated with our brachytherapy seeds
21M +
Brachytherapy seeds supplied to date
We Invest - 52,000 Sq ft
Footprint of the state-of-the-art Arrotek design facility
250+ Physicians
Rely on our brachytherapy seeds for their patients
About Theragenics
We design and deliver innovative solutions that consistently improve patient outcomes.
Careers
Ready to join a dynamic team committed to advancing medical device innovation?
Contact Theragenics
Get in touch to learn more about our products and services.